Tanasescu, M.-D.; Rosu, A.-M.; Minca, A.; Grigorie, M.-M.; Timofte, D.; Ionescu, D.
Cardiometabolic 2.0: Redefining Cardiovascular Prevention Through SGLT-2 Inhibitors and GLP-1 Receptor Agonists. Life 2026, 16, 756.
https://doi.org/10.3390/life16050756
AMA Style
Tanasescu M-D, Rosu A-M, Minca A, Grigorie M-M, Timofte D, Ionescu D.
Cardiometabolic 2.0: Redefining Cardiovascular Prevention Through SGLT-2 Inhibitors and GLP-1 Receptor Agonists. Life. 2026; 16(5):756.
https://doi.org/10.3390/life16050756
Chicago/Turabian Style
Tanasescu, Maria-Daniela, Andrei-Mihnea Rosu, Alexandru Minca, Maria-Mihaela Grigorie, Delia Timofte, and Dorin Ionescu.
2026. "Cardiometabolic 2.0: Redefining Cardiovascular Prevention Through SGLT-2 Inhibitors and GLP-1 Receptor Agonists" Life 16, no. 5: 756.
https://doi.org/10.3390/life16050756
APA Style
Tanasescu, M.-D., Rosu, A.-M., Minca, A., Grigorie, M.-M., Timofte, D., & Ionescu, D.
(2026). Cardiometabolic 2.0: Redefining Cardiovascular Prevention Through SGLT-2 Inhibitors and GLP-1 Receptor Agonists. Life, 16(5), 756.
https://doi.org/10.3390/life16050756